McKesson Operating Income 2010-2023 | MCK

McKesson annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • McKesson operating income for the quarter ending December 31, 2023 was $0.642B, a 48.27% decline year-over-year.
  • McKesson operating income for the twelve months ending December 31, 2023 was $3.673B, a 8.95% decline year-over-year.
  • McKesson annual operating income for 2023 was $4.381B, a 114.97% increase from 2022.
  • McKesson annual operating income for 2022 was $2.038B, a 140.44% decline from 2021.
  • McKesson annual operating income for 2021 was $-5.04B, a 302.49% decline from 2020.
McKesson Annual Operating Income
(Millions of US $)
2023 $4,381
2022 $2,038
2021 $-5,040
2020 $2,489
2019 $886
2018 $762
2017 $7,122
2016 $3,545
2015 $2,968
2014 $2,439
2013 $2,347
2012 $2,124
2011 $1,821
2010 $2,008
2009 $1,196
McKesson Quarterly Operating Income
(Millions of US $)
2023-12-31 $642
2023-09-30 $951
2023-06-30 $1,100
2023-03-31 $980
2022-12-31 $1,241
2022-09-30 $1,124
2022-06-30 $1,036
2022-03-31 $633
2021-12-31 $298
2021-09-30 $539
2021-06-30 $568
2021-03-31 $1,010
2020-12-31 $-7,362
2020-09-30 $634
2020-06-30 $678
2020-03-31 $869
2019-12-31 $360
2019-09-30 $626
2019-06-30 $634
2019-03-31 $-569
2018-12-31 $683
2018-09-30 $689
2018-06-30 $83
2018-03-31 $-944
2017-12-31 $834
2017-09-30 $239
2017-06-30 $633
2017-03-31 $4,739
2016-12-31 $831
2016-09-30 $580
2016-06-30 $972
2016-03-31 $740
2015-12-31 $920
2015-09-30 $954
2015-06-30 $931
2015-03-31 $700
2014-12-31 $800
2014-09-30 $787
2014-06-30 $681
2014-03-31 $605
2013-12-31 $493
2013-09-30 $686
2013-06-30 $655
2013-03-31 $667
2012-12-31 $498
2012-09-30 $606
2012-06-30 $576
2012-03-31 $682
2011-12-31 $492
2011-09-30 $478
2011-06-30 $472
2011-03-31 $623
2010-12-31 $307
2010-09-30 $417
2010-06-30 $474
2010-03-31 $573
2009-12-31 $509
2009-09-30 $467
2009-06-30 $459
2009-03-31 $498
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $70.359B $276.711B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.554B 19.62
West Pharmaceutical Services (WST) United States $28.238B 47.74
Cardinal Health (CAH) United States $25.184B 15.14
Align Technology (ALGN) United States $23.613B 45.61
Cooper (COO) United States $17.928B 27.13
Labcorp (LH) United States $17.493B 14.94
Henry Schein (HSIC) United States $9.406B 16.27
DENTSPLY SIRONA (XRAY) United States $6.412B 16.90
Merit Medical Systems (MMSI) United States $4.299B 24.59
Patterson (PDCO) United States $2.346B 11.24
STAAR Surgical (STAA) United States $2.337B 73.57
CONMED (CNMD) United States $2.156B 19.56
Atrion (ATRI) United States $0.747B 38.46
Lifevantage (LFVN) United States $0.079B 12.85
Pro-Dex (PDEX) United States $0.065B 24.67
Biolase (BIOL) United States $0.005B 0.00